Orchestra BioMed Holdings OBIO
NASDAQ OBIO
$6.25 +0.17 (+2.80%)
As of: Sep 30, 2026 · 2:33 PM EDT

Orchestra BioMed Holdings (OBIO) Revenue (2022 - 2026)

Updated

Orchestra BioMed Holdings' Revenue came in at $88,000 for Q2 2026, down 89.5% from $836,000 a year earlier and down 20.0% from the prior quarter.

Analysis

Orchestra BioMed Holdings (OBIO) Revenue (2022 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Orchestra BioMed Holdings reported Revenue of $31.98 million, up 986.1% year-over-year; for FY2025, it was $33.48 million.

  • Revenue carries a three-year compound annual growth rate of 111.6% (FY2022 to FY2025).
  • Going back by year, Revenue was $2.64 million in FY2024 (-4.4%), $2.76 million in FY2023 (-21.9%) and $3.53 million in FY2022.
  • The Q2 2026 figure represents the lowest quarterly Revenue in data going back to Q1 2022.
  • Year-over-year, Revenue increased in three of the last seven quarters, with an average decline of 1.4%.
  • The fastest year-over-year change in Revenue over five years came in Q3 2024 (growth of 135.6%), and the weakest in Q2 2026 (a decline of 89.5%).
  • Business Quant data shows OBIO's Revenue at $110,000 (Q1 2026), $30.92 million (Q4 2025) and $861,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 11.99 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn 12.59 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 6.27 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn 2.89 Bn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 9.76 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 6.59 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 5.44 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 1.74 Bn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 4.98 Bn
10 Orchestra BioMed Holdings 365.44 Mn -31.16 Mn 63,000.00 88,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 88,000.00
Mar 31, 2026 110,000.00
Dec 31, 2025 30.92 Mn
Sep 30, 2025 861,000.00
Jun 30, 2025 836,000.00
Mar 31, 2025 868,000.00
Dec 31, 2024 253,000.00
Sep 30, 2024 987,000.00
Jun 30, 2024 778,000.00
Mar 31, 2024 620,000.00
Dec 31, 2023 262,000.00
Sep 30, 2023 419,000.00
Jun 30, 2023 915,000.00
Mar 31, 2023 1.16 Mn
Dec 31, 2022 1.10 Mn
Sep 30, 2022 1.16 Mn
Jun 30, 2022 401,000.00
Mar 31, 2022 866,000.00
API Access

Orchestra BioMed Holdings Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=OBIO&period=max&api_key=YOUR_API_KEY